ARCHIVES

Funding Exceptions, Skipovers, While Limited At NCI, Become Crucial Issues; NCAB To Be Brief On Details

This article is from The Cancer Letter archive.

Vol. 09 No. 01 | January 7, 1983

Download PDF Visit The Full Archive

Related Articles

NCI, FDA Near Agreement On INDs; Young, Hoogstraten Clash On Rubidazone

January 14, 1977

Nobel In Chemistry For Work Linking Carbon Atoms

October 8, 2010

Anti-NCI Forces Fail to Raid $70 Million from Cancer Program

September 26, 1975

NCAB Member Pollin Organizes Minority Outreach Effort

January 4, 1991

In Brief: Congress Finished Spending Bill, Reagan Signs It; NCI Gets $1.402 Billion, a $174.5 Million Raise

October 24, 1986

Bills Would Give FDA Authority to Approve Generic Biotech Drugs.

February 16, 2007